<Special Seminar>Molecular mechanism of sleep-wake regulation
- フォーマット:
- 論文
- 責任表示:
- Urade, Yoshihiro
- 言語:
- 英語
- 出版情報:
- 弘前大学大学院医学研究科・弘前医学会, 2010-07-08
- 著者名:
- Urade, Yoshihiro
- 掲載情報:
- 弘前医学
- ISSN:
- 0439-1721
- 巻:
- 61
- 通号:
- Supplement
- 開始ページ:
- S164
- 終了ページ:
- S173
- バージョン:
- publisher
- 概要:
- Prostaglandin( PG) D2 is the most potent endogenous sleep-promoting substance thus far reported and its sleep-inducing mechanism is the best characterized at the molecular level. PGD2 is produced by lipocalin-type PGD synthase (L-PGDS) loca … lized in the leptomeninges, choroid plexus, and oligodendrocytes in the brain and is secreted into the cerebrospinal fluid as a sleep hormone. PGD2 stimulates DP1 receptors localized in the arachnoid membrane at the basal forebrain to release adenosine as a paracrine sleep-promoting molecule, which activates adenosine A2A receptor-expressing neurons located in the basal forebrain. These cells subsequently excite the sleep-active neurons in the ventrolateral preoptic area and concomitantly suppress the tuberomammillary nucleus, a histaminergic arousal center, through GABAergic and galaninergic inhibitory projection, to induce sleep. The administration of a PGD synthase inhibitor (SeCl4), DP1 antagonist (ONO-4127Na) or adenosine A2 receptor antagonist (caffeine) induces insomnia, indicating that the PGD2-adenosine system is crucial for the maintenance of physiological sleep. 続きを見る
- URL:
- http://hdl.handle.net/10129/3683
類似資料:
Academic Press | |
精神神経系薬物治療研究基金 |
Springer, R.G. Landes |
Cold Spring Harbor Laboratory Press |
Elsevier |
Oxford University Press | |
Plenum Medical |
[s.n.], Nakanishi Printing[m] |
Wiley, Israel Program for Scientific Translations |
Elsevier |